COX inhibitor
Showing 1 - 25 of 8,082
Effect of Drug Trial (Dexamethasone, Etoricoxib 60 mg)
Not yet recruiting
- Effect of Drug
- Dexamethasone
- Etoricoxib 60 mg
- (no location specified)
Dec 2, 2021
Colorectal Cancer Trial in Guangzhou (PD-1 antibody + cox inhibitor)
Unknown status
- Colorectal Cancer
- PD-1 antibody + cox inhibitor
-
Guangzhou, Guangdong, China
- +1 more
Jun 25, 2020
Pain, Postoperative Trial in Houston (Celecoxib, Acetaminophen, Placebo)
Recruiting
- Pain, Postoperative
- Celecoxib
- +2 more
-
Houston, TexasUniversity of Texas School of Dentistry
Oct 4, 2021
Amyotrophic Lateral Sclerosis Trial in Australia, United States (Fasudil (WP-0512))
Recruiting
- Amyotrophic Lateral Sclerosis
- Fasudil (WP-0512)
-
Phoenix, Arizona
- +11 more
Oct 28, 2022
Leukoplakia, Oral, Benign Tumors Trial in New York, Cochin, Trivandrum (sulindac, Placebo)
Completed
- Leukoplakia, Oral
- Benign Neoplasms
- sulindac
- Placebo
-
New York, New York
- +2 more
Oct 23, 2020
Dental Pain Trial in Austin, Salt Lake City (Placebo; oral, ARRY-371797, p38 inhibitor; oral, Celecoxib, COX-2 inhibitor; oral)
Completed
- Dental Pain
- Placebo; oral
- +2 more
-
Austin, Texas
- +1 more
Feb 7, 2021
Breast Cancer Trial in Cleveland (celecoxib, vinorelbine ditartrate)
Terminated
- Breast Cancer
- celecoxib
- vinorelbine ditartrate
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020
Low Back Pain Trial in Seoul (procedure, other, drug)
Unknown status
- Low Back Pain
- open or endoscopic discectomy
- +7 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 25, 2020
Tranexamic Acid for Angiotensin-converting Enzyme
Completed
- Angioedema
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Chronic Rhinosinusitis With Nasal Polyps, Aspirin-exacerbated Respiratory Disease Trial in London (Celecoxib, Placebo)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
- Celecoxib
- Placebo
-
London, Ontario, CanadaSt. Joseph's Healthcare London
Apr 5, 2022
Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)
Completed
- Lymphangioleiomyomatosis (LAM)
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 18, 2022
Contraception Trial in Stanford (Ulipristal Acetate 30 MG Oral Tablet)
Completed
- Contraception
- Ulipristal Acetate 30 MG Oral Tablet
-
Stanford, CaliforniaStanford University
Jun 24, 2019
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Ovulation, Luteal Development Trial in Portland (Celebrex, Placebo)
Completed
- Ovulation
- Luteal Development
- Celebrex
- Placebo
-
Portland, OregonOregon Health & Science University
May 24, 2019
Healthy Trial in Philadelphia (Blood draw)
Active, not recruiting
- Healthy
- Blood draw
-
Philadelphia, PennsylvaniaThe Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022
Surgical Wound, Post Operative Pain Trial in Belgrade (Etoricoxib 90 Mg Oral Tablet, Dexamethasone 4mg)
Completed
- Surgical Wound
- Post Operative Pain
- Etoricoxib 90 Mg Oral Tablet
- Dexamethasone 4mg
-
Belgrade, SerbiaSchool of Dental medicine, University of Belgrade
Mar 28, 2023
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Electronic Health Record Review
- +6 more
- (no location specified)
Oct 27, 2023
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,
Recruiting
- Colorectal Cancer
- +3 more
- Glutaminase Inhibitor CB-839
- +5 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Mar 29, 2022
Pancreatic Tumors Trial in Tel Hashomer, Tel-Aviv, Tsrifin (Propranolol and etodolac, Placebo)
Recruiting
- Pancreatic Neoplasms
- Propranolol and etodolac
- Placebo
-
Tel Hashomer, Israel
- +2 more
Nov 19, 2019
Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)
Recruiting
- Rheumatoid Arthritis
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
May 10, 2022